National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

paroxetine hydrochloride
The hydrochloride salt form of paroxetine, a phenylpiperidine derivative and a selective serotonin reuptake inhibitor (SSRI) with antidepressant and anxiolytic properties. Paroxetine binds to the pre-synaptic serotonin transporter complex resulting in negative allosteric modulation of the complex thereby blocking reuptake of serotonin by the pre-synaptic transporter. Inhibition of serotonin recycling enhances serotonergic function through serotonin accumulation in the synaptic cleft, resulting in long-term desensitization and downregulation of 5HT1 (serotonin) receptors and leading to symptomatic relief of depressive illness. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Paxil



Previous:Paraplat, Paraplatin, parathyroid hormone-related protein (1-36), paricalcitol, Parlodel
Next:PARP inhibitor AZD2281, PARP-1 inhibitor AG014699, pasireotide, patient-specific follicular lymphoma-derived anti-idiotype vaccine, Pavabid

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov